171 related articles for article (PubMed ID: 9498753)
21. Terminal deoxynucleotidyl transferase deficiency reduces the incidence of autoimmune nephritis in (New Zealand Black x New Zealand White)F1 mice.
Conde C; Weller S; Gilfillan S; Marcellin L; Martin T; Pasquali JL
J Immunol; 1998 Dec; 161(12):7023-30. PubMed ID: 9862739
[TBL] [Abstract][Full Text] [Related]
22. Immunization with peptides derived from the idiotypic region of lupus-associated autoantibodies delays the development of lupus nephritis in the (SWR x NZB)F1 murine model.
Stoll ML; Price KD; Silvin CJ; Jiang F; Gavalchin J
J Autoimmun; 2007 Aug; 29(1):30-7. PubMed ID: 17459659
[TBL] [Abstract][Full Text] [Related]
23. Long-term anti-CD154 dosing in nephritic mice is required to maintain survival and inhibit mediators of renal fibrosis.
Kalled SL; Cutler AH; Ferrant JL
Lupus; 2001; 10(1):9-22. PubMed ID: 11243513
[TBL] [Abstract][Full Text] [Related]
24. Disruption of antigen-induced inflammatory responses in CD40 ligand knockout mice.
Lei XF; Ohkawara Y; Stämpfli MR; Mastruzzo C; Marr RA; Snider D; Xing Z; Jordana M
J Clin Invest; 1998 Mar; 101(6):1342-53. PubMed ID: 9502776
[TBL] [Abstract][Full Text] [Related]
25. Marked inhibition of transplant vascular sclerosis by in vivo-mobilized donor dendritic cells and anti-CD154 mAb.
Wang Z; Morelli AE; Hackstein H; Kaneko K; Thomson AW
Transplantation; 2003 Aug; 76(3):562-71. PubMed ID: 12923445
[TBL] [Abstract][Full Text] [Related]
26. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
27. Rapamycin prevents the development of nephritis in lupus-prone NZB/W F1 mice.
Lui SL; Yung S; Tsang R; Zhang F; Chan KW; Tam S; Chan TM
Lupus; 2008 Apr; 17(4):305-13. PubMed ID: 18413412
[TBL] [Abstract][Full Text] [Related]
28. Blockade of CD40-CD40 ligand protects against renal injury in chronic proteinuric renal disease.
Kairaitis L; Wang Y; Zheng L; Tay YC; Wang Y; Harris DC
Kidney Int; 2003 Oct; 64(4):1265-72. PubMed ID: 12969144
[TBL] [Abstract][Full Text] [Related]
29. An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus.
Bahjat FR; Pine PR; Reitsma A; Cassafer G; Baluom M; Grillo S; Chang B; Zhao FF; Payan DG; Grossbard EB; Daikh DI
Arthritis Rheum; 2008 May; 58(5):1433-44. PubMed ID: 18438845
[TBL] [Abstract][Full Text] [Related]
30. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
Matsumoto K; Watanabe N; Akikusa B; Kurasawa K; Matsumura R; Saito Y; Iwamoto I; Saito T
Arthritis Rheum; 2003 Feb; 48(2):486-94. PubMed ID: 12571859
[TBL] [Abstract][Full Text] [Related]
31. IdLNF1-specific T cell clones accelerate the production of IdLNF1 + IgG and nephritis in SNF1 mice.
Knupp CJ; Uner AH; Tatum AH; Kakanar JR; Gavalchin J
J Autoimmun; 1995 Jun; 8(3):367-80. PubMed ID: 7575998
[TBL] [Abstract][Full Text] [Related]
32. Treatment of lupus nephritis in adult (NZB + NZW)F1 mice by cortisone-facilitated tolerance to nucleic acid antigens.
Borel Y; Lewis RM; André-Schwartz J; Stollar BD; Diener E
J Clin Invest; 1978 Feb; 61(2):276-86. PubMed ID: 304453
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
34. A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis.
Boumpas DT; Furie R; Manzi S; Illei GG; Wallace DJ; Balow JE; Vaishnaw A;
Arthritis Rheum; 2003 Mar; 48(3):719-27. PubMed ID: 12632425
[TBL] [Abstract][Full Text] [Related]
35. Resting B cells from autoimmune lupus-prone New Zealand Black and (New Zealand Black x New Zealand White)F1 mice are hyper-responsive to T cell-derived stimuli.
Jongstra-Bilen J; Vukusic B; Boras K; Wither JE
J Immunol; 1997 Dec; 159(12):5810-20. PubMed ID: 9550377
[TBL] [Abstract][Full Text] [Related]
36. Treatment with antibody reactive with the nephritogenic idiotype, IdLNF1, suppresses its production and leads to prolonged survival of (NZB x SWR)F1 mice.
Uner AH; Knupp CJ; Tatum AH; Gavalchin J
J Autoimmun; 1994 Feb; 7(1):27-44. PubMed ID: 8198700
[TBL] [Abstract][Full Text] [Related]
37. Reduced fragmentation of apoptotic chromatin is associated with nephritis in lupus-prone (NZB x NZW)F(1) mice.
Zykova SN; Seredkina N; Benjaminsen J; Rekvig OP
Arthritis Rheum; 2008 Mar; 58(3):813-25. PubMed ID: 18311834
[TBL] [Abstract][Full Text] [Related]
38. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
[TBL] [Abstract][Full Text] [Related]
39. The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus.
Huang W; Sinha J; Newman J; Reddy B; Budhai L; Furie R; Vaishnaw A; Davidson A
Arthritis Rheum; 2002 Jun; 46(6):1554-62. PubMed ID: 12115186
[TBL] [Abstract][Full Text] [Related]
40. Prevention and reversal of lupus in NZB/NZW mice by costimulatory blockade with adeno-associated virus-mediated gene transfer.
Ye X; Zhu T; Bastacky S; McHale T; Li J; Xiao X
Arthritis Rheum; 2005 Dec; 52(12):3975-86. PubMed ID: 16329128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
